Outcomes and Quality of Life Following Heller’s Myotomy for Achalasia With a Sigmoid Esophagus


About this study

The purpose of this study is to assess symptoms and quality of life in patients following Heller’s cardiomyotomy for achalasia in the context of a sigmoid esophagus.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All adult patients (>/equal to 18 years) undergoing cardiomyotomy for achalasia (with or without an anti-reflux procedure) with a sigmoid esophagus.

Exclusion Criteria: 

  • None


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Stephen Cassivi, M.D.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions